Montelukast Sodium Tablet, Film Coated
Product Images NDC 0904-6808

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 0904-6808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

Chemical structure of Montelukast Sodium, depicting its molecular framework including aromatic rings, a cyclopropyl group, and sodium carboxylate moiety.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph showing mean percent change from baseline over weeks of treatment. The x-axis represents weeks of treatment including a washout period, and the y-axis shows mean percent change. Two lines compare placebo and Montelukast Sodium, with Montelukast Sodium showing a greater increase over time compared to placebo.*

FDA Label Image

C545bd81 2e5a 22f3 E053 2a95a90a3654 00

Montelukast Sodium 10 mg film-coated tablets unit dose label by Major Pharmaceuticals. The label indicates prescription use for adults 15 years and older, with a package count of 100 tablets. It includes dosage strength, manufacturer details, storage instructions, and a barcode at the bottom.*

FDA Label Image

Camberlogo1

FDA Label Image

Camberlogo2

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.